Proposed Data Collection Submitted for Public Comment and Recommendations, 55809-55810 [2022-19558]

Download as PDF Federal Register / Vol. 87, No. 175 / Monday, September 12, 2022 / Notices Jeffrey M. Zirger, Lead, Information Collection Review Office, Office of Scientific Integrity, Office of Science, Centers for Disease Control and Prevention. [FR Doc. 2022–19557 Filed 9–9–22; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60Day–22–1338; Docket No. CDC–2022– 0106] Proposed Data Collection Submitted for Public Comment and Recommendations Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice with comment period. AGENCY: The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other federal agencies the opportunity to comment on a continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled, Evaluation of the Effectiveness of the Training and Education Modules in the North American Fatigue Management Program. This is an observational study evaluating 180 long-haul and regional truck drivers in a naturalistic driving study over eight months, using questionnaires, in-vehicle monitor system, Actigraphy devices, and smartphones for data collection. DATES: CDC must receive written comments on or before November 14, 2022. ADDRESSES: You may submit comments, identified by Docket No. CDC–2022– 0106 by any of the following methods: • Federal eRulemaking Portal: www.regulations.gov. Follow the instructions for submitting comments. • Mail: Jeffrey M. Zirger, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS H21–8, Atlanta, Georgia 30329. Instructions: All submissions received must include the agency name and Docket Number. CDC will post, without change, all relevant comments to www.regulations.gov. Please note: Submit all Federal comments through the Federal eRulemaking portal lotter on DSK11XQN23PROD with NOTICES1 SUMMARY: VerDate Sep<11>2014 17:06 Sep 09, 2022 Jkt 256001 (www.regulations.gov) or by U.S. mail to the address listed above. FOR FURTHER INFORMATION CONTACT: To request more information on the proposed project or to obtain a copy of the information collection plan and instruments, contact Jeffrey M. Zirger, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS H21–8, Atlanta, Georgia 30329; Telephone: 404–639–7570; Email: omb@ cdc.gov. SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501–3520), Federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. In addition, the PRA also requires Federal agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, including each new proposed collection, each proposed extension of existing collection of information, and each reinstatement of previously approved information collection before submitting the collection to the OMB for approval. To comply with this requirement, we are publishing this notice of a proposed data collection as described below. The OMB is particularly interested in comments that will help: 1. Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; 2. Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; 3. Enhance the quality, utility, and clarity of the information to be collected; 4. Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submissions of responses; and 5. Assess information collection costs. Proposed Project Evaluation of the Effectiveness of the Training and Education Modules in the North American Fatigue Management Program (OMB Control No. 0920–1338, Exp. 06/30/2023)—Extension—National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC). PO 00000 Frm 00031 Fmt 4703 Sfmt 4703 55809 Background and Brief Description The mission of the National Institute for Occupational Safety and Health (NIOSH) is to promote safety and health at work for all people through research and prevention. Reducing fatiguerelated crashes is one of the top 10 changes needed to reduce transportation accidents and save lives identified by the National Transportation Safety Board (NTSB) and a National Occupational Research Agenda (NORA) priority. Fatigue is a preventable cause of truck crashes. The North American Fatigue Management Program (NAFMP) was developed by the Federal Motor Carrier Safety Administration, Transport Canada, and other entities to address commercial motor vehicle (CMV) driver fatigue through a comprehensive approach that delivers prevention information to carriers, dispatchers, drivers, and family members. In 2015, the National Academy of Sciences published the report ‘‘Commercial motor vehicle driver fatigue, long-term health, and highway safety research needs’’ that identified the need for fully evaluating the NAFMP so that recommendations for implementation of NAFMP are supported by scientific evidence. NIOSH is collaborating with the Federal Motor Carrier Safety Administration (FMCSA) to ensure the success of the proposed study. NIOSH is requesting an extension to account for the additional time necessary to recruit more respondents. Data will be collected from CMV drivers (hereafter referred to as ‘‘driver’’) during their application to participate in the study, briefing session, study participation, and debriefing session. Data collection will primarily focus on driving performance, sleep, and sleepiness. These outcomes will be compared between pre-rollout of the NAFMP (in which drivers will operate as they did before their participation in the study) and post-rollout of the NAFMP training and education modules (in which drivers and managers will operate with increased knowledge, strategies, and techniques to reduce their fatigue). All drivers interested in participating in the study may complete the application. A briefing session will be scheduled with drivers who are found eligible for the study. During the briefing session, drivers who provide informed consent will be enrolled in the study. Drivers will have a debriefing session if a driver chooses to withdraw from the study early or upon completion of the eight-month participation period. The sample of drivers in the study will include those employed as drivers E:\FR\FM\12SEN1.SGM 12SEN1 55810 Federal Register / Vol. 87, No. 175 / Monday, September 12, 2022 / Notices at the participating carriers. A convenience sample of 180 eligible drivers who have a valid Class-A commercial driver’s license (CDL) and work at the participating company in regional and long-haul operations for at least one year will be eligible for the study. The study sample will include approximately 90 regional and 90 longhaul drivers. There will be no required minimum number of female or minority drivers to be included. Data will be collected during each phase: (1) In the application, drivers will be asked to provide their name and contact information (home address, telephone number, and email address) to allow contact from the research team regarding their eligibility for the study; (2) In the briefing session, drivers will be asked to complete the Background Questionnaire; and (3) During the study, information collection will occur week) and middle (second month) of the baseline phase, and the middle (fifth month) and end (eighth month) of the intervention phase); (f) a questionnaire to assess corporate practices and corporate safety climate will be given to managers at the participating carriers (these will be completed by managers at the beginning (first week) of the study and end (eighth month) of the intervention phase); and (g) during the field study, carriers will be asked to provide information concerning crashes and roadside violations occurring during each driver’s period of study participation. Administrative cost information (e.g., equipment, labor, etc.) will also be collected from the carrier to evaluate cost-benefit of the intervention. CDC requests OMB approval for an estimated 5,278 annual burden hours. There is no cost to respondents other than their time to participate. through several streams: (a) real-time fatigue monitoring system installed in the participating driver’s vehicle; (b) smart phone apps to collect psychomotor vigilance test, Karolinska Sleepiness Scale, sleep log, difficulty of drive scale, degree of drive hazards scale, a fatigue scale, and a stress scale; (c) an electronic logging device to collect data on the driver’s duty and driving; (d) a wrist actigraphy to collect data on driver sleep and wake times. Drivers will be asked to sync the actigraph with a smartphone app daily; (e) smartphone or web-based questionnaires including Exercise and Food Consumption Questionnaire, the Quality of Life short form 36 version-2 questionnaire (SF–36v2), Family Interactions Questionnaire, and Job Descriptive Index (these will be completed by drivers at four different intervals, including the beginning (first ESTIMATED ANNUALIZED BURDEN HOURS Form name Carrier Management ......................... Participation Agreement ................... Retrieval of Company Monthly Roadside Violations/Crash Reports. Retrieval of Company Administrative Costs. Management Practice questionnaire (Time 1). Management Practice questionnaire (Time 2). Application to Participate ................. Actigraph Training ............................ Background Questionnaire ............... Daily Smartphone Questions ........... PVT .................................................. Exercise and Food Consumption Questionnaire. SF–36v2 ........................................... Family Interactions Questionnaire ... Safety Climate Questionnaire .......... Job Descriptive Index ....................... Post-Study Questionnaire ................ Phone Briefings ................................ Drivers ............................................... Total ........................................... ........................................................... Jeffrey M. Zirger, Lead, Information Collection Review Office, Office of Scientific Integrity, Office of Science, Centers for Disease Control and Prevention. [FR Doc. 2022–19558 Filed 9–9–22; 8:45 am] Number of responses per respondent Number of respondents Type of respondent 1 8 1 90/60 1 12 1 16 2 32 5 1 45/60 4 5 1 45/60 4 150 90 90 90 90 90 1 1 1 720 720 4 12/60 10/60 45/60 1/60 3/60 20/60 30 15 68 1,080 3,240 120 90 90 90 90 90 90 4 4 4 4 1 8 30/60 15/60 10/60 30/60 1 6/60 180 90 60 180 90 72 ........................ ........................ ........................ 5,278 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention lotter on DSK11XQN23PROD with NOTICES1 [30Day–22–1011] Agency Forms Undergoing Paperwork Reduction Act Review In accordance with the Paperwork Reduction Act of 1995, the Centers for Disease Control and Prevention (CDC) 18:21 Sep 09, 2022 Jkt 256001 PO 00000 Frm 00032 Fmt 4703 Total burden (in hours) 1 1 BILLING CODE 4163–18–P VerDate Sep<11>2014 Average burden per response (in hours) Sfmt 4703 has submitted the information collection request titled ‘‘Emergency Epidemic Investigations’’ to the Office of Management and Budget (OMB) for review and approval. CDC previously published a ‘‘Proposed Data Collection Submitted for Public Comment and Recommendations’’ notice on April 18, 2022 to obtain comments from the public and affected agencies. CDC did not receive comments related to the previous notice. This notice serves to E:\FR\FM\12SEN1.SGM 12SEN1

Agencies

[Federal Register Volume 87, Number 175 (Monday, September 12, 2022)]
[Notices]
[Pages 55809-55810]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-19558]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-22-1338; Docket No. CDC-2022-0106]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing effort to reduce public burden and maximize the 
utility of government information, invites the general public and other 
federal agencies the opportunity to comment on a continuing information 
collection, as required by the Paperwork Reduction Act of 1995. This 
notice invites comment on a proposed information collection project 
titled, Evaluation of the Effectiveness of the Training and Education 
Modules in the North American Fatigue Management Program. This is an 
observational study evaluating 180 long-haul and regional truck drivers 
in a naturalistic driving study over eight months, using 
questionnaires, in-vehicle monitor system, Actigraphy devices, and 
smartphones for data collection.

DATES: CDC must receive written comments on or before November 14, 
2022.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2022-
0106 by any of the following methods:
     Federal eRulemaking Portal: www.regulations.gov. Follow 
the instructions for submitting comments.
     Mail: Jeffrey M. Zirger, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE, MS H21-8, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. CDC will post, without change, all relevant comments 
to www.regulations.gov.
    Please note: Submit all Federal comments through the Federal 
eRulemaking portal (www.regulations.gov) or by U.S. mail to the address 
listed above.

FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact Jeffrey M. Zirger, Information Collection 
Review Office, Centers for Disease Control and Prevention, 1600 Clifton 
Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7570; 
Email: [email protected].

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
Federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to the OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    The OMB is particularly interested in comments that will help:
    1. Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    2. Evaluate the accuracy of the agency's estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    3. Enhance the quality, utility, and clarity of the information to 
be collected;
    4. Minimize the burden of the collection of information on those 
who are to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submissions of responses; and
    5. Assess information collection costs.

Proposed Project

    Evaluation of the Effectiveness of the Training and Education 
Modules in the North American Fatigue Management Program (OMB Control 
No. 0920-1338, Exp. 06/30/2023)--Extension--National Institute for 
Occupational Safety and Health (NIOSH), Centers for Disease Control and 
Prevention (CDC).

Background and Brief Description

    The mission of the National Institute for Occupational Safety and 
Health (NIOSH) is to promote safety and health at work for all people 
through research and prevention. Reducing fatigue-related crashes is 
one of the top 10 changes needed to reduce transportation accidents and 
save lives identified by the National Transportation Safety Board 
(NTSB) and a National Occupational Research Agenda (NORA) priority.
    Fatigue is a preventable cause of truck crashes. The North American 
Fatigue Management Program (NAFMP) was developed by the Federal Motor 
Carrier Safety Administration, Transport Canada, and other entities to 
address commercial motor vehicle (CMV) driver fatigue through a 
comprehensive approach that delivers prevention information to 
carriers, dispatchers, drivers, and family members. In 2015, the 
National Academy of Sciences published the report ``Commercial motor 
vehicle driver fatigue, long-term health, and highway safety research 
needs'' that identified the need for fully evaluating the NAFMP so that 
recommendations for implementation of NAFMP are supported by scientific 
evidence. NIOSH is collaborating with the Federal Motor Carrier Safety 
Administration (FMCSA) to ensure the success of the proposed study. 
NIOSH is requesting an extension to account for the additional time 
necessary to recruit more respondents.
    Data will be collected from CMV drivers (hereafter referred to as 
``driver'') during their application to participate in the study, 
briefing session, study participation, and debriefing session. Data 
collection will primarily focus on driving performance, sleep, and 
sleepiness. These outcomes will be compared between pre-rollout of the 
NAFMP (in which drivers will operate as they did before their 
participation in the study) and post-rollout of the NAFMP training and 
education modules (in which drivers and managers will operate with 
increased knowledge, strategies, and techniques to reduce their 
fatigue). All drivers interested in participating in the study may 
complete the application. A briefing session will be scheduled with 
drivers who are found eligible for the study. During the briefing 
session, drivers who provide informed consent will be enrolled in the 
study. Drivers will have a debriefing session if a driver chooses to 
withdraw from the study early or upon completion of the eight-month 
participation period.
    The sample of drivers in the study will include those employed as 
drivers

[[Page 55810]]

at the participating carriers. A convenience sample of 180 eligible 
drivers who have a valid Class-A commercial driver's license (CDL) and 
work at the participating company in regional and long-haul operations 
for at least one year will be eligible for the study. The study sample 
will include approximately 90 regional and 90 long-haul drivers. There 
will be no required minimum number of female or minority drivers to be 
included.
    Data will be collected during each phase: (1) In the application, 
drivers will be asked to provide their name and contact information 
(home address, telephone number, and email address) to allow contact 
from the research team regarding their eligibility for the study; (2) 
In the briefing session, drivers will be asked to complete the 
Background Questionnaire; and (3) During the study, information 
collection will occur through several streams: (a) real-time fatigue 
monitoring system installed in the participating driver's vehicle; (b) 
smart phone apps to collect psychomotor vigilance test, Karolinska 
Sleepiness Scale, sleep log, difficulty of drive scale, degree of drive 
hazards scale, a fatigue scale, and a stress scale; (c) an electronic 
logging device to collect data on the driver's duty and driving; (d) a 
wrist actigraphy to collect data on driver sleep and wake times. 
Drivers will be asked to sync the actigraph with a smartphone app 
daily; (e) smartphone or web-based questionnaires including Exercise 
and Food Consumption Questionnaire, the Quality of Life short form 36 
version-2 questionnaire (SF-36v2), Family Interactions Questionnaire, 
and Job Descriptive Index (these will be completed by drivers at four 
different intervals, including the beginning (first week) and middle 
(second month) of the baseline phase, and the middle (fifth month) and 
end (eighth month) of the intervention phase); (f) a questionnaire to 
assess corporate practices and corporate safety climate will be given 
to managers at the participating carriers (these will be completed by 
managers at the beginning (first week) of the study and end (eighth 
month) of the intervention phase); and (g) during the field study, 
carriers will be asked to provide information concerning crashes and 
roadside violations occurring during each driver's period of study 
participation. Administrative cost information (e.g., equipment, labor, 
etc.) will also be collected from the carrier to evaluate cost-benefit 
of the intervention.
    CDC requests OMB approval for an estimated 5,278 annual burden 
hours. There is no cost to respondents other than their time to 
participate.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                      Average
                                                     Number of       Number of      burden per     Total burden
      Type of respondent            Form name       respondents    responses per   response  (in    (in hours)
                                                                    respondent        hours)
----------------------------------------------------------------------------------------------------------------
Carrier Management............  Participation                  1               1               1               1
                                 Agreement.
                                Retrieval of                   1               8           90/60              12
                                 Company Monthly
                                 Roadside
                                 Violations/
                                 Crash Reports.
                                Retrieval of                   1              16               2              32
                                 Company
                                 Administrative
                                 Costs.
                                Management                     5               1           45/60               4
                                 Practice
                                 questionnaire
                                 (Time 1).
                                Management                     5               1           45/60               4
                                 Practice
                                 questionnaire
                                 (Time 2).
Drivers.......................  Application to               150               1           12/60              30
                                 Participate.
                                Actigraph                     90               1           10/60              15
                                 Training.
                                Background                    90               1           45/60              68
                                 Questionnaire.
                                Daily Smartphone              90             720            1/60           1,080
                                 Questions.
                                PVT.............              90             720            3/60           3,240
                                Exercise and                  90               4           20/60             120
                                 Food
                                 Consumption
                                 Questionnaire.
                                SF-36v2.........              90               4           30/60             180
                                Family                        90               4           15/60              90
                                 Interactions
                                 Questionnaire.
                                Safety Climate                90               4           10/60              60
                                 Questionnaire.
                                Job Descriptive               90               4           30/60             180
                                 Index.
                                Post-Study                    90               1               1              90
                                 Questionnaire.
                                Phone Briefings.              90               8            6/60              72
                                                 ---------------------------------------------------------------
    Total.....................  ................  ..............  ..............  ..............           5,278
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific 
Integrity, Office of Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2022-19558 Filed 9-9-22; 8:45 am]
BILLING CODE 4163-18-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.